Approval · Notice of Compliance 24380 · 2020
ADDYI: Notice of Compliance 24380
Issued October 2, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24380
- Date
- October 2, 2020
- Company
- Searchlight Pharma Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in product ownershp
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ADDYI | 02473550 | Marketed |
Medicinal ingredients
- FLIBANSERIN 100 MG per TAB